Cargando…

Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin‐two cases

BACKGROUND: The majority of individuals with fragile X syndrome (FXS) have intellectual disability, behavioral problems, autism, and language deficits. IQ typically declines with age in boys with the full mutation. The results of preclinical studies demonstrated that metformin, a biguanide used to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Protic, Dragana, Aydin, Elber Y., Tassone, Flora, Tan, Maria M., Hagerman, Randi J., Schneider, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625129/ https://www.ncbi.nlm.nih.gov/pubmed/31104364 http://dx.doi.org/10.1002/mgg3.745

Ejemplares similares

Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2022)

Fragile X-Associated Neuropsychiatric Disorders (FXAND)
por: Hagerman, Randi J., et al.
Publicado: (2018)

Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014)

Fragile X Syndrome
por: McLennan, Yingratana, et al.
Publicado: (2011)

Metformin treatment in young children with fragile X syndrome
por: Biag, Hazel Maridith B., et al.
Publicado: (2019)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
por: Aydin, Elber Yuksel, et al.
Publicado: (2020)

Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome
por: Jasoliya, Mittal, et al.
Publicado: (2020)

New Targeted Treatments for Fragile X Syndrome
por: Protic, Dragana, et al.
Publicado: (2019)

Fragile X Syndrome
por: Saldarriaga, Wilmar, et al.
Publicado: (2014)

Genomic studies in fragile X premutation carriers
por: Lozano, Reymundo, et al.
Publicado: (2014)

Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome
por: Famula, Jessica, et al.
Publicado: (2022)

A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome
por: Hessl, David, et al.
Publicado: (2008)

Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome
por: Chonchaiya, Weerasak, et al.
Publicado: (2010)

Neural progenitor cells from an adult patient with fragile X syndrome
por: Schwartz, Philip H, et al.
Publicado: (2005)

Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions
por: Kim, Kyoungmi, et al.
Publicado: (2019)

Early Intervention Combined with Targeted Treatment Promotes Cognitive and Behavioral Improvements in Young Children with Fragile X Syndrome
por: Winarni, Tri Indah, et al.
Publicado: (2012)

Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders
por: Trajković, Jelena, et al.
Publicado: (2022)

Fragile X Syndrome: From Molecular Aspect to Clinical Treatment
por: Protic, Dragana D., et al.
Publicado: (2022)

Intranuclear inclusions in a fragile X mosaic male
por: Pretto, Dalyir I, et al.
Publicado: (2013)

Increased Pain Symptomatology Among Females vs. Males With Fragile X-Associated Tremor/Ataxia Syndrome
por: Johnson, Devon, et al.
Publicado: (2022)

Clinical and molecular correlates in fragile X premutation females
por: Jiraanont, Poonnada, et al.
Publicado: (2017)

Sequencing the unsequenceable: Expanded CGG-repeat alleles of the fragile X gene
por: Loomis, Erick W., et al.
Publicado: (2013)

Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers
por: Polussa, Jonathan, et al.
Publicado: (2014)

Aging in fragile X syndrome
por: Utari, Agustini, et al.
Publicado: (2010)

Prenatal Diagnosis of Fragile X: Can a Full Mutation Allele in the FMR1 Gene Contract to a Normal Size?
por: Manor, Esther, et al.
Publicado: (2017)

Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X Syndrome
por: Stöger, Reinhard, et al.
Publicado: (2011)

Immune Dysregulation as a Cause of Autoinflammation in Fragile X Premutation Carriers: Link between FMRI CGG Repeat Number and Decreased Cytokine Responses
por: Careaga, Milo, et al.
Publicado: (2014)

Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome
por: Careaga, Milo, et al.
Publicado: (2014)

Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017)

Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
por: Wang, Jun Yi, et al.
Publicado: (2022)

Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome
por: Salcedo-Arellano, Maria Jimena, et al.
Publicado: (2021)

Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome
por: Aishworiya, Ramkumar, et al.
Publicado: (2023)

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
por: Palumbo, Joseph M., et al.
Publicado: (2023)

Fragile X and autism: Intertwined at the molecular level leading to targeted treatments
por: Hagerman, Randi, et al.
Publicado: (2010)

Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries?
por: Protic, Dragana, et al.
Publicado: (2021)

Fragile X Premutation: Medications, Therapy and Lifestyle Advice
por: Sodhi, Deepika Kour, et al.
Publicado: (2021)

Molecular Biomarkers in Fragile X Syndrome
por: Zafarullah, Marwa, et al.
Publicado: (2019)

A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome
por: Ligsay, Andrew, et al.
Publicado: (2017)

Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome
por: Greco, Claudia M, et al.
Publicado: (2011)

Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS
por: Zafarullah, Marwa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sutf117i89mdsl398g4osfp3og